Asymmetric dimethylarginine (ADMA) in human blood: effects of extended haemodialysis in the critical...
Asymmetric dimethylarginine (ADMA) in human blood: effects of extended haemodialysis in the critically ill patient with acute kidney injury, protein binding to human serum albumin and proteolysis by thermolysin
About this item
Full title
Author / Creator
Publisher
Vienna: Springer Vienna
Journal title
Language
English
Formats
Publication information
Publisher
Vienna: Springer Vienna
Subjects
More information
Scope and Contents
Contents
Free, non-protein bound asymmetrically guanidine-dimethylated arginine (ADMA) is an endogenous inhibitor of nitric oxide (NO) synthesis. Human erythrocytic membrane comprises considerable amounts of large (>50 kDa) ADMA-containing proteins. Location in the erythrocyte membrane and identity and physiological functions of ADMA-containing proteins are...
Alternative Titles
Full title
Asymmetric dimethylarginine (ADMA) in human blood: effects of extended haemodialysis in the critically ill patient with acute kidney injury, protein binding to human serum albumin and proteolysis by thermolysin
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1753519081
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1753519081
Other Identifiers
ISSN
0939-4451
E-ISSN
1438-2199
DOI
10.1007/s00726-015-1991-4
